Showing results (251-260 of 453) with videos related to
Sort By:
Pageof 46
European Urology|September 23, 2018
Reporting and Interpreting Decision Curve Analysis: A Guide for InvestigatorsBen Van Calster, Laure Wynants, Jan F M Verbeek, et al.The Prostate|October 12, 2019
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk menMelissa J Assel, Hans David Ulmert, R Jeffery Karnes, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 6, 2023
Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancerVictor McPherson, Shiva M Nair, Amy L Tin, et al.Plos Pathogens|February 29, 2024
Ongoing evolution of the Mycobacterium tuberculosis lactate dehydrogenase reveals the pleiotropic effects of bacterial adaption to host pressureSydney Stanley, Xin Wang, Qingyun Liu, et al.Urology Practice|November 29, 2021
Shared Medical Appointments for Prostate Cancer Active Surveillance Follow-Up VisitsSigrid V Carlsson, Corinne Clauss, Nicole Benfante, et al.Prostate Cancer and Prostatic Diseases|November 4, 2021
Estimating patient health in prostate cancer treatment counselingGregory T Chesnut, Amy L Tin, Katherine A Fleshner, et al.European Urology Focus|August 28, 2022
Relationship Between Age, Comorbidity, and the Prevalence of Erectile DysfunctionFrancesco Pellegrino, Daniel D Sjoberg, Amy L Tin, et al.Clinical Chemistry|December 23, 2006
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancerThomas Steuber, Andrew J Vickers, Angel M Serio, et al.International Journal of Cancer|June 10, 2010
Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experienceAndrew J Vickers, Caroline J Savage, Fernando J Bianco, et al.BMJ (Clinical Research Ed.)|September 17, 2010
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control studyAndrew J Vickers, Angel M Cronin, Thomas Björk, et al.Pageof 46